A major producer and exporter of formulated, low-cost generic pharmaceuticals, India increased its exports to major … markets during 2011–17, including sub-Saharan Africa (SSA) and the United States. India is also taking steps to produce more … innovative pharmaceuticals through such measures as accessing U.S. technology through mergers, acquisitions, and licensing, and …

Novartis spent nearly 15 years seeking a patent in India for Glivec. That quest reached its dead end, at last, on April … 1st. India's Supreme Court rejected the Swiss drugmaker's patent. It represents critical issues related to intellectual … pharmaceutical trade in India in the future, as well as India's role as the “Pharmacy of the Developing World”. India's verdict is …

. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However …, India depends heavily on the import of several raw materials used to produce some of these medicines. Main Body: This paper … dependence, especially regarding the secure access to essential medicines. India needs a conducive ecosystem to capitalize on the …

tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …

current patent regime? In India, health being the main concern would necessarily require more sincere efforts on part of the …

decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain … intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments …

inadequate and unsystematic in India and there is a vast scope for improvement …